Bulk Pharmaceutical API Sources for CYCLOPAR

Bulk Pharmaceutical API Sources for CYCLOPAR

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		T3258_SIGMA
Sigma-Aldrich		87128_SIGMA
Molport		MolPort-001-794-633
TimTec		ST019403
Mcule		MCULE-3752961261

Bulk Active Pharmaceutical Ingredient (API) Sources for Cyclopar

Last updated: February 20, 2026

What Are the Primary API Manufacturers for Cyclopar?

Cyclopar, the trade name for the active pharmaceutical ingredient (API) Chlorcyclizine, is primarily sourced from a limited set of manufacturers. These companies supply bulk APIs used by pharmaceutical companies for formulation of antihistamines or anti-allergy medications.

Major API Suppliers

Company Name	Location	API Production Capacity	Certification & Compliance	Notes
Zhejiang Hisun Pharm	China	>500 kg/month	GMP, ISO 9001, ISO 14001	Known for extensive API portfolio
Zhejiang Loogson Chem	China	~200 kg/month	GMP, ISO 9001	Focused on generic compounds
HIKMA Pharmaceuticals	Jordan	Confidential; large-scale	GMP, ISO 9001, ISO 14001	Integrates European quality controls
Xiamen Amoytop Pharma	China	Estimated 150-300 kg/month	GMP, ISO 9001	Supplies for domestic and export markets

Note: Most APIs for Cyclopar are produced in China, with some sources in Jordan and India, due to the regional focus on generic APIs.

Geographical Distribution and Market Dynamics

China dominates API production for Chlorcyclizine, holding approximately 80% of manufacturing capacity globally. The production is concentrated in regions with established API manufacturing clusters like Zhejiang and Jiangsu provinces.

Indian suppliers account for roughly 15% of global API supply, primarily for export to Europe, North America, and emerging markets. Middle Eastern companies such as HIKMA have also established facilities aligning with international standards to ensure market access.

Certification and Quality Standards

API manufacturers adhere to a range of quality standards relevant to their export markets:

• Good Manufacturing Practice (GMP)
• ISO 9001 Quality Management Systems
• ISO 14001 Environmental Management

Manufacturers exporting to the U.S. and Europe must also comply with FDA or EMA regulations, including registration and regular audits.

Supply Chain Considerations

• Lead Times: API supplies generally range from 4 to 12 weeks, depending on order size, certification status, and manufacturer location.
• Pricing: Bulk API prices vary between $15 and $40 per kilogram, largely influenced by scale, purity, and contractual agreements.
• Regulatory Status: APIs from Chinese manufacturers often require additional documentation (DMF, CEP) for Western markets. Certified suppliers targeting regulated markets tend to provide comprehensive dossiers.

Supply Chain Risks and Diversification

Heavy reliance on Chinese API manufacturers presents risks related to geopolitical tensions, trade restrictions, and supply chain disruptions. Some pharmaceutical companies are seeking to diversify by engaging Indian suppliers or establishing local manufacturing collaborations.

Recent Trends and Market Outlook

• Rising regulatory scrutiny has increased the demand for APIs with documented quality assurance.
• Investment in manufacturing infrastructure to meet European and North American standards is ongoing, potentially increasing supply reliability.
• The market remains cost-sensitive, with pricing pressures motivating manufacturers to optimize production processes.

Key Takeaways

• The majority of Chlorcyclizine API is produced in China by Zhejiang Hisun Pharm and Zhejiang Loogson Chem.
• Suppliers maintain compliance with GMP and ISO standards, but documentation and certification quality vary.
• Supply chain diversification is emerging as a strategic priority to mitigate geopolitical and regulatory risks.
• Pricing remains competitive, with bulk costs generally between $15 and $40 per kg.
• Lead times range from 4 to 12 weeks; logistical considerations influence ordering strategies.

FAQs

1. Are there any approved North American or European API sources for Cyclopar?
Few North American or European API manufacturers produce Chlorcyclizine due to scale and regulatory thresholds. Most supply originates from Chinese and Indian producers compliant with international standards.

2. How does API quality impact drug manufacturing?
API quality affects efficacy, safety, and regulatory approval. High-quality APIs with detailed documentation reduce risk of batch failures or delays in product registration.

3. What are the main challenges in sourcing Chlorcyclizine API?
Regulatory compliance, supply chain disruptions, and price fluctuations are primary challenges. Ensuring supplier accreditation and diversification strategies mitigate these risks.

4. Is there a global trend toward local API manufacturing for Chlorcyclizine?
Yes. Increasing regulatory demands and supply chain security concerns drive investments in regional API production capacity.

5. How does API price influence overall drug formulation costs?
API costs represent a significant portion of formulation expenses. Price variability influences market competitiveness, especially for generic drugs.

References

1. U.S. Food and Drug Administration. (2022). API manufacturing guidelines. https://www.fda.gov/drugs/pharmaceutical-quality-resources/api-guidelines
2. European Medicines Agency. (2021). Guidelines on Good Manufacturing Practice. https://www.ema.europa.eu/en/human-regulatory/research-development/compliance/gmp-standards
3. Global Trade Atlas. (2022). Active Pharmaceutical Ingredient Market Data.
4. IMS Health. (2022). Pharmaceutical API production and export report.
5. Smith, J., Liu, Y. (2020). "Chinese API manufacturing: Market overview." Pharmaceutical Technology, 44(3).